SCHEMBL6837465

SCHEMBL6837465

COc1ccc(Cn2cc3c(n2)COC(C)c2sc(N)nc2-3)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AADAT Q8N5Z0 1/20 0.39
DRD2 P14416 1/20 0.37
KCNH2 Q12809 1/20 0.37
POLB P06746 2/20 0.34
ADORA1 P30542 4/20 0.33
ALDH1A1 P00352 2/20 0.33
KDM4E B2RXH2 1/20 0.33
MAPT P10636 1/20 0.33
MPI P34949 1/20 0.33
LTA4H P09960 1/20 0.33
RAB9A P51151 2/20 0.32
ACHE P22303 1/20 0.32
LMNA P02545 1/20 0.32
HPGD P15428 1/20 0.32
PDE5A O76074 1/20 0.32
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6837226 0.82 DRD2 (0.36) AADATDRD2KCNH2POLBADORA1
SCHEMBL6837211 0.81 ADORA1 (0.42) AADATDRD2KCNH2POLBADORA1
SCHEMBL368608 0.81 ADORA1 (0.40) AADATDRD2KCNH2POLBADORA1
SCHEMBL6837269 0.80 GRM4 (0.37) AADATPOLBALDH1A1KDM4EMAPT
SCHEMBL369019 0.79 DRD2 (0.37) AADATDRD2KCNH2POLBADORA1
SCHEMBL15260941 0.78 AADAT (0.42) AADATDRD2KCNH2ADORA1ALDH1A1
SCHEMBL6837318 0.76 ALDH1A1 (0.47) AADATDRD2KCNH2POLBADORA1
SCHEMBL369493 0.74 AADAT (0.42) AADATDRD2KCNH2ADORA1ALDH1A1
SCHEMBL371092 0.74 ADORA1 (0.39) AADATDRD2KCNH2POLBADORA1
SCHEMBL370750 0.72 DRD2 (0.35) AADATDRD2KCNH2POLBADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130210807-A1 Tricyclic Compounds as Allosteric Modulators of Metabotropic Glutamate Receptors. MERCK SHARP & DOHME CORP. 2013-08-15 US disclosed
WO-2012008999-A2 TRICYCLIC COMPOUNDS AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERCK SHARP & DOHME CORP. (US) 2012-01-19 WO disclosed
WO-2012006760-A1 TRICYCLIC COMPOUNDS AS ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS MERCK SHARP & DOHME CORP. (US) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130210807-A1 Tricyclic Compounds as Allosteric Modulators of Metabotropic Glutamate Receptors. GRM3, GRM6, GRM1 AADAT 3254/4885DRD2 103/4885KCNH2 285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.